Apr 05, 2017 at 21:42 | Source: PTI
Bayer Pharma Aktiengesellschaft and Bayer Australia Ltd had filed a patent infringement lawsuit against Generic Health Pty Ltd and Lupin Australia Pty Ltd, subsidiaries of the company, in the Federal Court of Australia, Lupin said in a filing to BSE.
Mar 26, 2017 at 22:00 | Source: PTI
"This is a great victory for our farmers, for citizens of India, as now the CCI has stopped the poison makers - Monsanto and Bayer from merging in India.
Feb 22, 2017 at 22:24 | Source: Reuters
German drugs and pesticides maker Bayer forecast a year without earnings growth for its agricultural products business on Wednesday, as it seeks to complete its USD66 billion deal to take over U.S. seeds giant Monsanto.
Feb 20, 2017 at 16:21 | Source: Moneycontrol.com
Axis Direct recommended hold rating on Bayer Cropscience with a target price of Rs 4050 in its research report dated February 17, 2017.
Feb 16, 2017 at 15:44 | Source: Moneycontrol.com
Lupin has received final USFDA approval for ANDA Moxifloxacin Hydrochloride Tablets, 400 mg. Generic of Avlox Tablets of Bayer Healthcare Pharmaceuticals, Inc.
Feb 08, 2017 at 08:00 | Source: CNBC-TV18
Infosys | Idea Cellular | Axis Bank | Tata Steel | Bharti Airtel | Bharat Forge | Hero Motocorp | Godawari Power | Jubilant Life Sciences | NHPC | Quess Corp | Titan Company and Jindal Stainless are stocks, which are in the news today.
Feb 07, 2017 at 22:14 | Source: PTI
Bayer CropScience Ltd today reported 26 per cent rise in its net profit at Rs 36.8 crore for the quarter ended December.
Jan 25, 2017 at 11:21 | Source: Moneycontrol.com
Bayer CropScience Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 07, 2017, to take on record the Unaudited Financial Results & Limited Review Report of the Company for the quarter ended December 31, 2016 (Q3).
Dec 14, 2016 at 11:33 | Source: Moneycontrol.com
Shareowner of Monsanto Company approved the merger of Monsanto with a wholly owned subsidiary of Bayer Aktiengesellschaft.
Dec 14, 2016 at 08:10 | Source: Reuters
Increased research and development spending by the combined companies and plans to develop a global seeds and biotechnology hub in St. Louis fuel hopes regulators will not block the deal, which was agreed upon in September, Monsanto CEO Hugh Grant said.